Investor's Business Daily on MSN
Stocks To Watch: KalVista Pharmaceuticals Sees Relative Strength Rating Jump To 83
KalVista Pharmaceuticals showed 0% earnings growth in the latest quarterly report. Sales increased 0%. The company earns the ...
BMS is exiting the first U.S.-China pharmaceutical joint venture. Kalexo Bio and Ollin Biosciences have launched with big ...
Vetagro marked a new chapter in its global story on Maryland’s Eastern Shore. A global leader in precision animal nutrition, ...
Bolstered by world-class centers of learning such as Harvard University and the Massachusetts Institute of Technology, Boston ...
Malvern biotech company Ocugen signed a deal for its experimental gene therapy with Kwangdong Pharmaceutical to bring in over $25 million.
Terra Oleo, a Singapore -based biotechnology company, today announced its emergence from stealth with US$3.1 million in funding from a group of investors, and support from Breakthrough Energy’s ...
VectorY Therapeutics has seen the shape of things to come—and it involves finding fresh ways to deliver its gene therapies into the brain. | VectorY Therapeutics has seen the shape of things to ...
Supporting Lexicon Pharmaceuticals’ decision to advance the non-opioid analgesic pilavapadin into late-stage ...
Learn more about whether Alnylam Pharmaceuticals, Inc. or Roivant Sciences Ltd. is a better investment based on AAII's A+ ...
Deal to foster Roche's activities to build 'robust,' differentiated pipeline that targets additional causes of metabolic disease - Anadolu Ajansı ...
A Madison, Wisconsin-based biotech with offices in Cambridge announced an $8 million seed round and a continuing partnership ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results